NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {🔍}

cells, apoptosis, trailr, trail, cll, article, cell, figure, google, scholar, cas, apoltrail, hgsetr, depsipeptide, caspase, patients, valproate, ngml, hdaci, trailinduced, trailhisle, death, signaling, surface, trailhis, expression, receptor, agonistic, receptors, data, human, preparations, ligand, clinical, tumor, cancer, nature, lymphocytic, mabs, primary, processing, chronic, shown, sensitization, primarily, activity, leukemia, forms, results, lines,

Topics {✒️}

nature portfolio permissions reprints tnf-related apoptosis-inducing ligand privacy policy epstein–barr virus-negative burkitt' nature 364 nature related apoptosis-inducing ligand tumour-necrosis factor superfamily advertising tumour necrosis factor histone deacetylase inhibitors related b-cell malignancies death-inducing signaling complex b-cell prolymphocytic leukemia chronic lymphocytic leukaemia development chronic lymphocytic leukemia isotype-matched control antibody conjugated mouse anti-dr4 anti-trail receptor antibodies social media regulate agonist-specific mechanisms materials media death receptor-induced apoptosis author correspondence expresses primarily trail-r1 adaptor molecule fadd/mort1 tumor cell lines permissions express surface trail-r2 histone deacetylase trail-r1 decreased markedly potentiating trail-induced-apoptosis potentiated trail-induced apoptosis primary tumor signals cell surface trail-r2 temperature-sensitive differential affinity cytotoxic ligand trail trail-r1-selective variants primary tumor cells apo2l/trail signals primarily recombinant apo2l/trail versions apoptosis-inducing ability sensitize tumor cells agonistic trail-r1 ab anti-fas antibody distinct caspase cascades cell death differ trail-r2 increased markedly

Questions {❓}

• Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
         description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
         datePublished:2005-04-29T00:00:00Z
         dateModified:2005-04-29T00:00:00Z
         pageStart:773
         pageEnd:782
         sameAs:https://doi.org/10.1038/sj.cdd.4401649
         keywords:
            chronic lymphocytic leukaemia
            tumor necrosis factor-apoptosis inducing ligand
            TRAIL-R1
            histone deacetylase inhibitors
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Stem Cells
            Apoptosis
            Cell Cycle Analysis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
         isPartOf:
            name:Cell Death & Differentiation
            issn:
               1476-5403
               1350-9047
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M MacFarlane
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S Inoue
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S L Kohlhaas
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Majid
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Harper
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D B J Kennedy
               affiliation:
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M J S Dyer
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G M Cohen
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
      description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
      datePublished:2005-04-29T00:00:00Z
      dateModified:2005-04-29T00:00:00Z
      pageStart:773
      pageEnd:782
      sameAs:https://doi.org/10.1038/sj.cdd.4401649
      keywords:
         chronic lymphocytic leukaemia
         tumor necrosis factor-apoptosis inducing ligand
         TRAIL-R1
         histone deacetylase inhibitors
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Stem Cells
         Apoptosis
         Cell Cycle Analysis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
      isPartOf:
         name:Cell Death & Differentiation
         issn:
            1476-5403
            1350-9047
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M MacFarlane
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S Inoue
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S L Kohlhaas
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Majid
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Harper
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D B J Kennedy
            affiliation:
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M J S Dyer
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G M Cohen
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Differentiation
      issn:
         1476-5403
         1350-9047
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M MacFarlane
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S Inoue
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S L Kohlhaas
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:A Majid
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:N Harper
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:D B J Kennedy
      affiliation:
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:M J S Dyer
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:G M Cohen
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(123)

• Learn how profitable http://www.ncbi.nlm.nih.gov/BLAST/ is on a monthly basis
• http://www.ebi.ac.uk/clustalw/'s revenue stream
• What's the income generated by https://doi.org/10.1172%2FJCI6926 each month?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Safety%20and%20antitumor%20activity%20of%20recombinant%20soluble%20Apo2%20ligand&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI6926&volume=104&pages=155-162&publication_year=1999&author=Ashkenazi%2CA&author=Pai%2CRC&author=Fong%2CS&author=Leung%2CS&author=Lawrence%2CDA&author=Marsters%2CSA&author=Blackie%2CC&author=Chang%2CL&author=McMurtrey%2CAE&author=Hebert%2CA&author=DeForge%2CL&author=Koumenis%2CIL&author=Lewis%2CD&author=Harris%2CL&author=Bussiere%2CJ&author=Koeppen%2CH&author=Shahrokh%2CZ&author=Schwall%2CRH making per month?
• How much does https://doi.org/10.1016%2F1074-7613%2895%2990057-8 rake in every month?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-682&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ&author=Din%2CWS&author=Huang%2CCP&author=Nicholl%2CJK&author=Sutherland%2CGR&author=Smith%2CTD&author=Rauch%2CC&author=Smith%2CCA&author=Goodwin%2CRG?
• How much revenue does https://doi.org/10.1074%2Fjbc.271.22.12687 produce monthly?
• http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20Apo-2%20ligand%2C%20a%20new%20member%20of%20the%20tumor%20necrosis%20factor%20cytokine%20family&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.271.22.12687&volume=271&pages=12687-12690&publication_year=1996&author=Pitti%2CRM&author=Marsters%2CSA&author=Ruppert%2CS&author=Donahue%2CCJ&author=Moore%2CA&author=Ashkenazi%2CA's total income per month
• Profit of https://doi.org/10.1038%2F5517
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat.%20Med.&doi=10.1038%2F5517&volume=5&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM&author=Chin%2CW&author=Jones%2CJ&author=Woodward%2CA&author=Le%2CT&author=Smith%2CC&author=Smolak%2CP&author=Goodwin%2CRG&author=Rauch%2CCT&author=Schuh%2CJC&author=Lynch%2CDH
• How much income does https://doi.org/10.1038%2F35008667 have?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=TRAIL%20receptor-2%20signals%20apoptosis%20through%20FADD%20and%20caspase-8&journal=Nat.%20Cell%20Biol.&doi=10.1038%2F35008667&volume=2&pages=241-243&publication_year=2000&author=Bodmer%2CJL&author=Holler%2CN&author=Reynard%2CS&author=Vinciguerra%2CP&author=Schneider%2CP&author=Juo%2CP&author=Blenis%2CJ&author=Tschopp%2CJ?
• Get to know https://doi.org/10.1016%2FS1074-7613%2800%2980212-5's earnings
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL-dependent%20recruitment%20of%20endogenous%20FADD%20and%20caspase-8%20to%20death%20receptors%204%20and%205&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980212-5&volume=12&pages=611-620&publication_year=2000&author=Kischkel%2CFC&author=Lawrence%2CDA&author=Chuntharapai%2CA&author=Schow%2CP&author=Kim%2CKJ&author=Ashkenazi%2CA?
• How much revenue does https://doi.org/10.1016%2FS1074-7613%2800%2980211-3 bring in?
• How much income is http://scholar.google.com/scholar_lookup?&title=FADD%2FMORT1%20and%20caspase-8%20are%20recruited%20to%20TRAIL%20receptors%201%20and%202%20and%20are%20essential%20for%20apoptosis%20mediated%20by%20TRAIL%20receptor%202&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980211-3&volume=12&pages=599-609&publication_year=2000&author=Sprick%2CMR&author=Weigand%2CMA&author=Rieser%2CE&author=Rauch%2CCT&author=Juo%2CP&author=Blenis%2CJ&author=Krammer%2CPH&author=Walczak%2CH earning monthly?
• How much does https://doi.org/10.1006%2Fexcr.2000.4835 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Protein%20complexes%20activate%20distinct%20caspase%20cascades%20in%20death%20receptor%20and%20stress-induced%20apoptosis&journal=Exp.%20Cell%20Res.&doi=10.1006%2Fexcr.2000.4835&volume=256&pages=27-33&publication_year=2000&author=Bratton%2CSB&author=MacFarlane%2CM&author=Cain%2CK&author=Cohen%2CGM net monthly?
• What are the earnings of https://doi.org/10.1038%2Fnrc821?
• How much income does http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumour-necrosis%20factor%20superfamily&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc821&volume=2&pages=420-430&publication_year=2002&author=Ashkenazi%2CA have?
• How much income is https://doi.org/10.1126%2Fscience.281.5381.1305 earning monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Death%20receptors%3A%20signaling%20and%20modulation&journal=Science&doi=10.1126%2Fscience.281.5381.1305&volume=281&pages=1305-1308&publication_year=1998&author=Ashkenazi%2CA&author=Dixit%2CVM make?
• https://doi.org/10.1038%2Fsj.cdd.4401187's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL%20and%20its%20death%20and%20decoy%20receptors&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401187&volume=10&pages=66-75&publication_year=2003&author=LeBlanc%2CHN&author=Ashkenazi%2CA gross monthly?
• How much cash flow does https://doi.org/10.1038%2F75045 have monthly?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Apoptosis%20induced%20in%20normal%20human%20hepatocytes%20by%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand&journal=Nat.%20Med.&doi=10.1038%2F75045&volume=6&pages=564-567&publication_year=2000&author=Jo%2CM&author=Kim%2CTH&author=Seol%2CDW&author=Esplen%2CJE&author=Dorko%2CK&author=Billiar%2CTR&author=Strom%2CSC?
• What is the earnings of https://doi.org/10.1046%2Fj.1365-2141.2000.02404.x?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20tumour%20necrosis%20factor%20%28TNF%29-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20receptors%20and%20sensitivity%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B-cell%20acute%20lymphoblastic%20leukaemia%20cells&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2000.02404.x&volume=111&pages=580-586&publication_year=2000&author=Clodi%2CK&author=Wimmer%2CD&author=Li%2CY&author=Goodwin%2CR&author=Jaeger%2CU&author=Mann%2CG&author=Gadner%2CH&author=Younes%2CA?
• How much revenue does https://doi.org/10.1038%2Fsj.onc.1205853 bring in?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B%20cell%20chronic%20lymphocytic%20leukaemia&journal=Oncogene&doi=10.1038%2Fsj.onc.1205853&volume=21&pages=6809-6818&publication_year=2002&author=MacFarlane%2CM&author=Harper%2CN&author=Snowden%2CRT&author=Dyer%2CMJ&author=Barnett%2CGA&author=Pringle%2CJH&author=Cohen%2CGM
• How much does https://doi.org/10.1046%2Fj.1365-2141.1997.4393250.x generate monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Activity%20of%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20in%20haematological%20malignancies&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.1997.4393250.x&volume=99&pages=618-624&publication_year=1997&author=Snell%2CV&author=Clodi%2CK&author=Zhao%2CS&author=Goodwin%2CR&author=Thomas%2CEK&author=Morris%2CSW&author=Kadin%2CME&author=Cabanillas%2CF&author=Andreeff%2CM&author=Younes%2CA generate?
• What's https://doi.org/10.1016%2Fj.drup.2004.03.002's gross income?
• How much does http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20therapeutic%20potential%20of%20TRAIL%20by%20cancer%20chemotherapy%20and%20irradiation%3A%20mechanisms%20and%20clinical%20implications&journal=Drug%20Resist.%20Update&doi=10.1016%2Fj.drup.2004.03.002&volume=7&pages=139-156&publication_year=2004&author=Shankar%2CS&author=Srivastava%2CRK bring in each month?
• https://doi.org/10.1038%2Fsj.cdd.4401535's revenue stream
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20inhibitors%20potentiate%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29-induced%20apoptosis%20in%20lymphoid%20malignancies&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401535&volume=11&issue=Suppl%202&pages=S193-206&publication_year=2004&author=Inoue%2CS&author=MacFarlane%2CM&author=Harper%2CN&author=Wheat%2CLM&author=Dyer%2CMJ&author=Cohen%2CGM?
• https://doi.org/10.1038%2F35106079 income
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20and%20cancer%3A%20causes%20and%20therapies&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2F35106079&volume=1&pages=194-202&publication_year=2001&author=Marks%2CP&author=Rifkind%2CRA&author=Richon%2CVM&author=Breslow%2CR&author=Miller%2CT&author=Kelly%2CWK?
• How much does https://doi.org/10.1016%2FS1471-4892%2803%2900084-5 net monthly?
• How much income does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases&journal=Curr.%20Opin.%20Pharmacol.&doi=10.1016%2FS1471-4892%2803%2900084-5&volume=3&pages=344-351&publication_year=2003&author=Marks%2CPA&author=Miller%2CT&author=Richon%2CVM have?
• How much profit does https://doi.org/10.1074%2Fjbc.M409578200 generate?
• http://scholar.google.com/scholar_lookup?&title=The%20C-terminal%20tails%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20and%20Fas%20receptors%20have%20opposing%20functions%20in%20Fas-associated%20Death%20Domain%20%28FADD%29%20recruitment%20and%20can%20regulate%20agonist-specific%20mechanisms%20of%20receptor%20activation&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M409578200&volume=279&pages=52479-52486&publication_year=2004&author=Thomas%2CLR&author=Johnson%2CRL&author=Reed%2CJC&author=Thorburn%2CA's revenue stream
• What's the profit of https://doi.org/10.1074%2Fjbc.272.41.25417?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Identification%20and%20molecular%20cloning%20of%20two%20novel%20receptors%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.272.41.25417&volume=272&pages=25417-25420&publication_year=1997&author=MacFarlane%2CM&author=Ahmad%2CM&author=Srinivasula%2CSM&author=Fernandes-Alnemri%2CT&author=Cohen%2CGM&author=Alnemri%2CES?
• What's https://doi.org/10.1074%2Fjbc.M101287200's gross income?
• How much does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20is%20a%20direct%20target%20of%20valproic%20acid%2C%20a%20potent%20anticonvulsant%2C%20mood%20stabilizer%2C%20and%20teratogen&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M101287200&volume=276&pages=36734-36741&publication_year=2001&author=Phiel%2CCJ&author=Zhang%2CF&author=Huang%2CEY&author=Guenther%2CMG&author=Lazar%2CMA&author=Klein%2CPS rake in every month?
• Financial intake of https://doi.org/10.1093%2Femboj%2F20.24.6969
• How much profit is http://scholar.google.com/scholar_lookup?&title=Valproic%20acid%20defines%20a%20novel%20class%20of%20HDAC%20inhibitors%20inducing%20differentiation%20of%20transformed%20cells&journal=EMBO%20J.&doi=10.1093%2Femboj%2F20.24.6969&volume=20&pages=6969-6978&publication_year=2001&author=Gottlicher%2CM&author=Minucci%2CS&author=Zhu%2CP&author=Kramer%2COH&author=Schimpf%2CA&author=Giavara%2CS&author=Sleeman%2CJP&author=Lo%20Coco%2CF&author=Nervi%2CC&author=Pelicci%2CPG&author=Heinzel%2CT making per month?
• How much does https://doi.org/10.1083%2Fjcb.148.6.1239 generate monthly?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Active%20caspases%20and%20cleaved%20cytokeratins%20are%20sequestered%20into%20cytoplasmic%20inclusions%20in%20TRAIL-induced%20apoptosis&journal=J.%20Cell%20Biol.&doi=10.1083%2Fjcb.148.6.1239&volume=148&pages=1239-1254&publication_year=2000&author=MacFarlane%2CM&author=Merrison%2CW&author=Dinsdale%2CD&author=Cohen%2CGM
• How much revenue does https://doi.org/10.1126%2Fscience.282.5393.1497 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Requirement%20for%20p53%20and%20p21%20to%20sustain%20G2%20arrest%20after%20DNA%20damage&journal=Science&doi=10.1126%2Fscience.282.5393.1497&volume=282&pages=1497-1501&publication_year=1998&author=Bunz%2CF&author=Dutriaux%2CA&author=Lengauer%2CC&author=Waldman%2CT&author=Zhou%2CS&author=Brown%2CJP&author=Sedivy%2CJM&author=Kinzler%2CKW&author=Vogelstein%2CB rake in every month?
• Financial intake of https://doi.org/10.1056%2FNEJM200012283432602
• What's http://scholar.google.com/scholar_lookup?&title=Genomic%20aberrations%20and%20survival%20in%20chronic%20lymphocytic%20leukemia&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJM200012283432602&volume=343&pages=1910-1916&publication_year=2000&author=Dohner%2CH&author=Stilgenbauer%2CS&author=Benner%2CA&author=Leupolt%2CE&author=Krober%2CA&author=Bullinger%2CL&author=Dohner%2CK&author=Bentz%2CM&author=Lichter%2CP's gross income?
• Learn how profitable https://doi.org/10.1002%2Fcncr.0680 is on a monthly basis
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Frequency%20and%20type%20of%20serious%20infections%20in%20fludarabine-refractory%20B-cell%20chronic%20lymphocytic%20leukemia%20and%20small%20lymphocytic%20lymphoma%3A%20implications%20for%20clinical%20trials%20in%20this%20patient%20population&journal=Cancer&doi=10.1002%2Fcncr.0680&volume=94&pages=2033-2039&publication_year=2002&author=Perkins%2CJG&author=Flynn%2CJM&author=Howard%2CRS&author=Byrd%2CJC generate?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477713's gross income?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Unmutated%20Ig%20V%28H%29%20genes%20are%20associated%20with%20a%20more%20aggressive%20form%20of%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1848-1854&publication_year=1999&author=Hamblin%2CTJ&author=Davis%2CZ&author=Gardiner%2CA&author=Oscier%2CDG&author=Stevenson%2CFK
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477712 income
• How much does http://scholar.google.com/scholar_lookup?&title=Ig%20V%20gene%20mutation%20status%20and%20CD38%20expression%20as%20novel%20prognostic%20indicators%20in%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1840-1847&publication_year=1999&author=Damle%2CRN&author=Wasil%2CT&author=Fais%2CF&author=Ghiotto%2CF&author=Valetto%2CA&author=Allen%2CSL&author=Buchbinder%2CA&author=Budman%2CD&author=Dittmar%2CK&author=Kolitz%2CJ&author=Lichtman%2CSM&author=Schulman%2CP&author=Vinciguerra%2CVP&author=Rai%2CKR&author=Ferrarini%2CM&author=Chiorazzi%2CN pull in?
• How much income is http://scholar.google.com/scholar_lookup?&title=Molecular%20determinants%20of%20response%20to%20TRAIL%20in%20killing%20of%20normal%20and%20cancer%20cells&journal=Clin.%20Cancer%20Res.&volume=6&pages=335-346&publication_year=2000&author=Kim%2CK&author=Fisher%2CMJ&author=Xu%2CSQ&author=el-Deiry%2CWS earning monthly?
• Discover the revenue of https://doi.org/10.1046%2Fj.1365-2141.2003.04699.x
• How much does http://scholar.google.com/scholar_lookup?&title=Chemical%20sensitization%20and%20regulation%20of%20TRAIL-induced%20apoptosis%20in%20a%20panel%20of%20B-lymphocytic%20leukaemia%20cell%20lines&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2003.04699.x&volume=123&pages=921-932&publication_year=2003&author=Kang%2CJ&author=Kisenge%2CRR&author=Toyoda%2CH&author=Tanaka%2CS&author=Bu%2CJ&author=Azuma%2CE&author=KomadaY%2C generate monthly?
• What is the monthly revenue of https://doi.org/10.1074%2Fjbc.M910438199?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Temperature-sensitive%20differential%20affinity%20of%20TRAIL%20for%20its%20receptors.%20DR5%20is%20the%20highest%20affinity%20receptor&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M910438199&volume=275&pages=23319-23325&publication_year=2000&author=Truneh%2CA&author=Sharma%2CS&author=Silverman%2CC&author=Khandekar%2CS&author=Reddy%2CMP&author=Deen%2CKC&author=McLaughlin%2CMM&author=Srinivasula%2CSM&author=Livi%2CGP&author=Marshall%2CLA&author=Alnemri%2CES&author=Williams%2CWV&author=Doyle%2CML bring in?
• https://doi.org/10.1182%2Fblood-2003-12-4333's total income per month
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20myelodysplastic%20syndromes%20with%20valproic%20acid%20alone%20or%20in%20combination%20with%20all-trans%20retinoic%20acid&journal=Blood&doi=10.1182%2Fblood-2003-12-4333&volume=104&pages=1266-1269&publication_year=2004&author=Kuendgen%2CA&author=Strupp%2CC&author=Aivado%2CM&author=Bernhardt%2CA&author=Hildebrandt%2CB&author=Haas%2CR&author=Germing%2CU&author=Gattermann%2CN?
• How much does https://doi.org/10.1097%2F00062752-200207000-00010 gross monthly?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20as%20therapeutic%20targets%20in%20hematologic%20malignancies&journal=Curr.%20Opin.%20Hematol.&doi=10.1097%2F00062752-200207000-00010&volume=9&pages=322-332&publication_year=2002&author=Melnick%2CA&author=Licht%2CJD?
• https://doi.org/10.1074%2Fjbc.M410660200 income
• How much profit does http://scholar.google.com/scholar_lookup?&title=Receptor-selective%20mutants%20of%20apoptosis-inducing%20ligand%202L%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20reveal%20a%20greater%20contribution%20of%20death%20receptor%20%28DR%29%205%20than%20DR4%20to%20apoptosis%20signaling&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M410660200&volume=280&pages=2205-2212&publication_year=2005&author=Kelley%2CRF&author=Totpal%2CK&author=Lindstrom%2CSH&author=Mathieu%2CM&author=Billeci%2CK&author=Deforge%2CL&author=Pai%2CR&author=Hymowitz%2CSG&author=Ashkenazi%2CA generate?
• What is the monthly revenue of https://doi.org/10.1038%2F91000?
• How much does http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20a%20novel%20anti-human%20DR5%20monoclonal%20antibody%20without%20hepatocyte%20cytotoxicity&journal=Nat.%20Med.&doi=10.1038%2F91000&volume=7&pages=954-960&publication_year=2001&author=Ichikawa%2CK&author=Liu%2CW&author=Zhao%2CL&author=Wang%2CZ&author=Liu%2CD&author=Ohtsuka%2CT&author=Zhang%2CH&author=Mountz%2CJD&author=Koopman%2CWJ&author=Kimberly%2CRP&author=Zhou%2CT earn?
• What are the total earnings of https://doi.org/10.1182%2Fblood.V98.3.795?
• How much does http://scholar.google.com/scholar_lookup?&title=TRAIL%2FApo2L%20ligand%20selectively%20induces%20apoptosis%20and%20overcomes%20drug%20resistance%20in%20multiple%20myeloma%3A%20therapeutic%20applications&journal=Blood&doi=10.1182%2Fblood.V98.3.795&volume=98&pages=795-804&publication_year=2001&author=Mitsiades%2CCS&author=Treon%2CSP&author=Mitsiades%2CN&author=Shima%2CY&author=Richardson%2CP&author=Schlossman%2CR&author=Hideshima%2CT&author=Anderson%2CKC bring in each month?
• How much does https://doi.org/10.1038%2F364806a0 rake in every month?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Lethal%20effect%20of%20the%20anti-Fas%20antibody%20in%20mice&journal=Nature&doi=10.1038%2F364806a0&volume=364&pages=806-809&publication_year=1993&author=Ogasawara%2CJ&author=Watanabe-Fukunaga%2CR&author=Adachi%2CM&author=Matsuzawa%2CA&author=Kasugai%2CT&author=Kitamura%2CY&author=Itoh%2CN&author=Suda%2CT&author=Nagata%2CS produce monthly?
• How much does https://doi.org/10.1038%2F86397 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Differential%20hepatocyte%20toxicity%20of%20recombinant%20Apo2L%2FTRAIL%20versions&journal=Nat.%20Med.&doi=10.1038%2F86397&volume=7&pages=383-385&publication_year=2001&author=Lawrence%2CD&author=Shahrokh%2CZ&author=Marsters%2CS&author=Achilles%2CK&author=Shih%2CD&author=Mounho%2CB&author=Hillan%2CK&author=Totpal%2CK&author=DeForge%2CL&author=Schow%2CP&author=Hooley%2CJ&author=Sherwood%2CS&author=Pai%2CR&author=Leung%2CS&author=Khan%2CL&author=Gliniak%2CB&author=Bussiere%2CJ&author=Smith%2CCA&author=Strom%2CSS&author=Kelley%2CS&author=Fox%2CJA&author=Thomas%2CD&author=Ashkenazi%2CA generate monthly?
• https://doi.org/10.1074%2Fjbc.M404541200 income
• How much does http://scholar.google.com/scholar_lookup?&title=Death%20induction%20by%20recombinant%20native%20TRAIL%20and%20its%20prevention%20by%20a%20caspase%209%20inhibitor%20in%20primary%20human%20esophageal%20epithelial%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M404541200&volume=279&pages=40044-40052&publication_year=2004&author=Kim%2CSH&author=Kim%2CK&author=Kwagh%2CJG&author=Dicker%2CDT&author=Herlyn%2CM&author=Rustgi%2CAK&author=Chen%2CY&author=El-Deiry%2CWS generate monthly?
• How much cash flow does https://doi.org/10.1038%2Fsj.cdd.4401331 have monthly?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Human%20normal%20hepatocytes%20are%20susceptible%20to%20apoptosis%20signal%20mediated%20by%20both%20TRAIL-R1%20and%20TRAIL-R2&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401331&volume=11&pages=203-207&publication_year=2004&author=Mori%2CE&author=Thomas%2CM&author=Motoki%2CK&author=Nakazawa%2CK&author=Tahara%2CT&author=Tomizuka%2CK&author=Ishida%2CI&author=Kataoka%2CS?
• What are the earnings of https://doi.org/10.1158%2F0008-5472.CAN-04-2599?
• How much income does http://scholar.google.com/scholar_lookup?&title=TRAIL%20inhibits%20tumor%20growth%20but%20is%20nontoxic%20to%20human%20hepatocytes%20in%20chimeric%20mice&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2599&volume=64&pages=8502-8506&publication_year=2004&author=Hao%2CC&author=Song%2CJH&author=Hsi%2CB&author=Lewis%2CJ&author=Song%2CDK&author=Petruk%2CKC&author=Tyrrell%2CDL&author=Kneteman%2CNM have?
• What's the profit of https://doi.org/10.1074%2Fjbc.M109893200?
• Get to know http://scholar.google.com/scholar_lookup?&title=Bcl-2%20and%20Bcl-xL%20inhibit%20CD95-mediated%20apoptosis%20by%20preventing%20mitochondrial%20release%20of%20Smac%2FDIABLO%20and%20subsequent%20inactivation%20of%20X-linked%20inhibitor-of-apoptosis%20protein&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M109893200&volume=277&pages=11345-11351&publication_year=2002&author=Sun%2CXM&author=Bratton%2CSB&author=Butterworth%2CM&author=MacFarlane%2CM&author=Cohen%2CGM's earnings
• How much revenue does https://doi.org/10.1074%2Fjbc.274.8.5053 produce monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Distinct%20caspase%20cascades%20are%20initiated%20in%20receptor-mediated%20and%20chemical-induced%20apoptosis&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.274.8.5053&volume=274&pages=5053-5060&publication_year=1999&author=Sun%2CXM&author=MacFarlane%2CM&author=Zhuang%2CJ&author=Wolf%2CBB&author=Green%2CDR&author=Cohen%2CGM gross monthly?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9058723 have monthly?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=p53%20abnormalities%20in%20B-cell%20prolymphocytic%20leukemia&journal=Blood&volume=89&pages=2015-2023&publication_year=1997&author=Lens%2CD&author=De%20Schouwer%2CPJ&author=Hamoudi%2CRA&author=Abdul-Rauf%2CM&author=Farahat%2CN&author=Matutes%2CE&author=Crook%2CT&author=Dyer%2CMJ&author=Catovsky%2CD each month?
• How much does https://doi.org/10.1038%2Fsj.thj.6200325 bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Characterisation%20of%20TP53%20abnormalities%20in%20chronic%20lymphocytic%20leukaemia&journal=Hematol.%20J.&doi=10.1038%2Fsj.thj.6200325&volume=5&pages=47-54&publication_year=2004&author=Thornton%2CPD&author=Gruszka-Westwood%2CAM&author=Hamoudi%2CRA&author=Atkinson%2CS&author=Kaczmarek%2CP&author=Morilla%2CRM&author=Hilditch%2CBL&author=A%27Hern%2CR&author=Matutes%2CE&author=Catovsky%2CD earn?
• What's the financial intake of https://doi.org/10.1038%2Fsj.leu.2403202?
• How much money does http://scholar.google.com/scholar_lookup?&title=Design%20and%20standardization%20of%20PCR%20primers%20and%20protocols%20for%20detection%20of%20clonal%20immunoglobulin%20and%20T-cell%20receptor%20gene%20recombinations%20in%20suspect%20lymphoproliferations%3A%20report%20of%20the%20BIOMED-2%20Concerted%20Action%20BMH4-CT98-3936&journal=Leukemia&doi=10.1038%2Fsj.leu.2403202&volume=17&pages=2257-2317&publication_year=2003&author=van%20Dongen%2CJJ&author=Langerak%2CAW&author=Bruggemann%2CM&author=Evans%2CPA&author=Hummel%2CM&author=Lavender%2CFL&author=Delabesse%2CE&author=Davi%2CF&author=Schuuring%2CE&author=Garcia-Sanz%2CR&author=van%20Krieken%2CJH&author=Droese%2CJ&author=Gonzalez%2CD&author=Bastard%2CC&author=White%2CHE&author=Spaargaren%2CM&author=Gonzalez%2CM&author=Parreira%2CA&author=Smith%2CJL&author=Morgan%2CGJ&author=Kneba%2CM&author=Macintyre%2CEA make?
• See how much https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=references makes per month
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20MacFarlane?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20MacFarlane%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Inoue earn?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Inoue%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20L%20Kohlhaas income
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20L%20Kohlhaas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Majid
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Majid%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N%20Harper have?
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N%20Harper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20B%20J%20Kennedy
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20B%20J%20Kennedy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20J%20S%20Dyer?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20J%20S%20Dyer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20M%20Cohen's gross income?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20M%20Cohen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Chronic%20lymphocytic%20leukemic%20cells%20exhibit%20apoptotic%20signaling%20via%20TRAIL-R1&author=M%20MacFarlane%20et%20al&contentID=10.1038%2Fsj.cdd.4401649©right=Springer%20Nature%20Limited&publication=1350-9047&publicationDate=2005-04-29&publisherName=SpringerNature&orderBeanReset=true generate?
• What is the earnings of https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=citation?
• How much cash flow does https://doi.org/10.1007/s12032-023-02276-3 have monthly?
• How much does https://doi.org/10.1038/s41375-023-02035-3 rake in every month?
• How much profit is https://doi.org/10.1038/s41418-022-01059-z making per month?
• How much does https://doi.org/10.1038/cddis.2017.423 rake in every month?
• How much profit does https://doi.org/10.1038/cdd.2015.174 make?
• How much income is https://www.protocols.io/ earning monthly?
• How much money does https://www.natureindex.com/ make?
• Profit of http://www.naturechina.com
• Revenue of https://www.natureasia.com/ja-jp

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref